Vestal Point Capital, LP

Source: SEC Form 13F · as of Mar 2026

Vestal Point Capital, LP holds 55 biotech & pharma companies tracked by BioSniper, totaling $2.05B in value as of Mar 2026 (SEC Form 13F).

Companies held

55

Total value held

$2.05B

CompanySharesValue
RVMDREVOLUTION MEDICINES, INC.2,375,000$231.0M
BMRNBIOMARIN PHARMACEUTICAL INC3,575,000$202.0M
NBIXNEUROCRINE BIOSCIENCES INC1,250,000$164.7M
RGENREPLIGEN CORP925,000$109.0M
APGEApogee Therapeutics, Inc.1,100,000$92.6M
DYNDyne Therapeutics, Inc.4,000,000$72.5M
SNYSanofi1,400,000$67.5M
SRRKScholar Rock Holding Corp1,324,422$65.1M
BMYBRISTOL MYERS SQUIBB CO1,000,000$60.6M
VERAVera Therapeutics, Inc.1,368,159$55.0M
TERNTerns Pharmaceuticals, Inc.1,000,000$52.7M
GMEDGlobus Medical Inc.610,520$52.6M
NUVLNuvalent, Inc.481,715$49.4M
COGTCogent Biosciences, Inc.1,230,888$47.4M
RAPPRapport Therapeutics, Inc.1,436,229$44.9M
IRONDisc Medicine, Inc.700,000$44.8M
UTHRUNITED THERAPEUTICS Corp75,000$44.5M
CLDXCelldex Therapeutics, Inc.1,224,165$38.8M
KALVKalVista Pharmaceuticals, Inc.1,850,000$37.2M
XENEXenon Pharmaceuticals Inc.639,900$37.2M
PTGXProtagonist Therapeutics, Inc326,159$34.4M
DNLIDenali Therapeutics Inc.1,773,326$34.0M
REGNREGENERON PHARMACEUTICALS, INC.40,000$30.9M
VKTXViking Therapeutics, Inc.914,147$29.7M
INSPInspire Medical Systems Inc.539,269$27.8M
TRVITrevi Therapeutics, Inc.2,166,504$25.8M
SLNOSOLENO THERAPEUTICS INC730,000$24.4M
NKTRNEKTAR THERAPEUTICS285,000$20.5M
CYTKCYTOKINETICS INC300,000$19.8M
AZNASTRAZENECA PLC100,000$19.7M
WSTWest Pharmaceutical Services Inc.75,000$18.8M
GEHCGE HealthCare Technologies Inc.250,000$17.8M
ZBHZimmer Biomet Holdings Inc.190,000$17.2M
MDGLMADRIGAL PHARMACEUTICALS, INC.31,468$16.5M
DMRADamora Therapeutics, Inc.600,000$15.5M
AGIOAGIOS PHARMACEUTICALS, INC.450,000$15.2M
SVRASavara Inc2,600,052$14.2M
TARSTarsus Pharmaceuticals, Inc.200,000$14.0M
SRZNSurrozen Inc.338,611$9.9M
ARVNARVINAS, INC.905,465$9.6M
MPLTMapLight Therapeutics, Inc.420,000$8.5M
FULCFulcrum Therapeutics, Inc.1,100,000$8.4M
MYGNMYRIAD GENETICS INC1,648,000$7.4M
OLMAOlema Pharmaceuticals, Inc.428,551$6.4M
QUREuniQure N.V.358,996$5.9M
PALIPALISADE BIO, INC.2,500,000$4.4M
ZBIOZenas BioPharma, Inc.200,000$3.9M
GERNGERON CORP2,540,000$3.8M
MNPRMonopar Therapeutics65,418$3.6M
ZURAZura Bio Ltd511,000$3.0M
URGNUroGen Pharma Ltd.139,079$2.5M
TYRATyra Biosciences, Inc.54,000$2.1M
RGNXREGENXBIO Inc.108,525$909K
MGNXMACROGENICS INC280,000$809K
ABSIAbsci Corporation232,219$697K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Vestal Point Capital, LP — Biotech 13F Holdings & Portfolio | BioSniper